ArticleBreast cancer (Dove Medical Press)2025

Efficacy of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer: A Real-World Retrospective Cohort Study in China.

Yuxin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.